asal naloxone and flumazenil effects on cigarette and cannabis craving and abstinence
Phase 1
Recruiting
- Conditions
- Tobacco use disorderCannabis use disorder
- Registration Number
- ACTRN12617000325303
- Lead Sponsor
- Go Medical Industries Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method